#USA #Manufacturing #Biopharmaceutical #Wilson #ABEC

ABEC Expands Its Manufacturing Footprint in Wilson, North Carolina

ABEC, a renowned leader in providing tailored solutions and services for biopharmaceutical manufacturing, has officially unveiled its latest manufacturing facility in Wilson, North Carolina. This significant milestone will be celebrated in a grand opening ceremony scheduled for September 24, 2026, at 9:00 AM. The event will bring together company executives, employees, community partners, and local representatives to mark this important occasion in the company’s continued growth.

The new manufacturing site will bolster ABEC's global manufacturing network and enhance its capacity to support the rapidly growing biopharmaceutical industry. Strategically located in one of the fastest-growing life sciences regions of the United States, the facility will increase ABEC's manufacturing capabilities while simultaneously creating high-quality jobs in the fields of manufacturing and engineering in Eastern North Carolina.

Scott Pickering, the Chief Executive Officer of ABEC, emphasized the importance of this new site, stating, "The opening of our Wilson facility represents another crucial milestone in ABEC's commitment to supporting the global biopharmaceutical industry. This investment expands our production capabilities, brings us closer to our customers in the Southeastern United States, and strengthens our ability to provide the most comprehensive portfolio of bioprocess equipment, consumables, and technical solutions in the industry. We are proud to become a part of the Wilson community and look forward to building long-term partnerships throughout the region."

The Wilson facility will produce bioprocess equipment and consumables essential for the development and production of life-saving biologics, vaccines, and other advanced therapies. This site complements ABEC's existing manufacturing operations in Bethlehem, Pennsylvania, Springfield, Missouri, and Fermoy and Kells in Ireland, reinforcing the company’s position as the largest specialized manufacturing network for process equipment and solutions in the biopharmaceutical sector.

The opening festivities will include a ribbon-cutting ceremony, facility tours, and speeches from ABEC leaders and local community representatives. This celebration will recognize the collective efforts of employees, contractors, community partners, and local officials who were instrumental in bringing the project to fruition.

Founded in 1974, ABEC has established itself as a premier provider of customized process solutions and services for the biotechnology manufacturing sector. A majority of pharmaceutical and biotechnology firms globally count on ABEC as a partner, with many leading therapies being produced using equipment and processes developed by the company. ABEC’s unique value proposition stems from deep experience, extensive in-house capabilities, a flexible approach, and long-standing credibility. From process development and equipment design to manufacturing, installation, and customer service, ABEC supports its clients in reducing costs, shortening time-to-market, and enhancing productivity.

As the biopharmaceutical landscape continues to evolve, ABEC's expansion in Wilson is not just a business decision; it’s a strategic move to position itself as a key player in a critical industry that contributes significantly to global health. ABEC’s commitment to innovation and community engagement is set to enhance its role within the biopharmaceutical sector while also paving the way for further advancements in healthcare solutions.